JRCT ID: jRCT2080220011
Registered date:01/09/2005
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Renal anemia |
Date of first enrollment | 01/09/2005 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : Epoetin beta INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Injection |
Outcome(s)
Primary Outcome | Efficacy and safety |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | 1.20 years - 80 years of age 2.hemoglobin between 9.0 g/dl to 12.0 g/dl 3.serum ferritin level and over 100 ng/ml or transferrin saturation and over 20% |
Exclude criteria |
Related Information
Primary Sponsor | Chugai Pharmaceutical Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-050011 |
Contact
Public contact | |
Name | |
Address | clinical-trials@chugai-pharm.co.jp |
Telephone | |
Affiliation | Chugai Pharmaceutical Co., LTD. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |